eli lilly tirzepatide fda approval New Medication approved by the for Chronic Weight Management! FDA confirms tirzepatide shortage is
Description
Medicaid GLP-1 coverage varies significantly by state, with some programs covering semaglutide and tirzepatide for weight loss while others restrict access to diabetes-only indications
Gastroparesis was suspected due to semaglutide use
Generic Semaglutide of Dr Reddys is set to launch in India and up to 87 countries post-patent expiry for affordable obesity treatment.
Clinicians should maintain vigilance, especially in adolescents and individuals self-prescribing for weight loss
